Is Tatva Chintan Pharma Chem Limited a good investment? Tatva Chintan Pharma Chem Limited (TATVA.NS) is currently trading at 1153.10 INR. Market analysts have a consensus price target of 1390.00 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 67.85. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Tatva Chintan Pharma Chem Limited is expected to release its next earnings report on July 29, 2026. The market consensus estimate for Forward EPS is 38.40.
For income investors, Tatva Chintan Pharma Chem Limited pays a dividend yield of 0.09%.
Yes, it pays an annual dividend of 1.00 INR (0.09% yield).
Tatva Chintan Pharma Chem Limited is classified as a Stock.
The next earnings date is projected to be July 29, 2026. The company currently has a trailing EPS of 17.93.
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
1.00 INR
|
| Oct. 22, 2026 (estimated) | 1.0000 |
| ▸2025 |
1.00 INR
|
| Oct. 3, 2025 | 1.0000 |
| ▸2024 |
2.00 INR
|
| Sept. 27, 2024 | 2.0000 |
| ▸2023 |
2.00 INR
|
| Oct. 22, 2023 | 2.0000 |
| ▸2022 |
2.00 INR
|
| Oct. 22, 2022 | 2.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Tatva Chintan Pharma Chem Limited | Oct 03, 2025 | Paid | 1.0 INR |
Community Discussion